Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02831348 · ClinicalTrials.gov registry record

Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases

A clinical trial of Asthma and Cystic Fibrosis, sponsored by Boston Children's Hospital.

Completed
Registry status
59
Enrollment target
1
Study location

NCT02831348 is a study of Asthma and Cystic Fibrosis that has completed, run by Boston Children's Hospital. The registered enrollment target is 59 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02831348, a study of Asthma and Cystic Fibrosis, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
59 participants
Enrollment target
1
Study location

Study Summary

This is a pilot cross-sectional study of measured transcutaneous CO-oximetry in children with inflammatory and non-inflammatory conditions.

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2015-10
Est. Completion 2021-12

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT02831348

The ClinicalTrials.gov registry entry for NCT02831348 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.

NCT02831348 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02831348 about?

NCT02831348 is a clinical study titled "Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases". This is a pilot cross-sectional study of measured transcutaneous CO-oximetry in children with inflammatory and non-inflammatory conditions.

What is the current status of trial NCT02831348?

This trial is currently completed. The enrollment target is 59 participants. The study started on 2015-10. Estimated completion is 2021-12.

What conditions does trial NCT02831348 study?

This clinical trial studies the following conditions: Asthma, Cystic Fibrosis, Pneumonia, Allergic Rhinitis.

Who is sponsoring clinical trial NCT02831348?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02831348 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.